Trade AstraZeneca ^AZN

16,079 Shares of AstraZeneca Plc $AZN Acquired by Provenance Wealth Advisors LLC

11,643 Shares of AstraZeneca Plc $AZN Acquired by ARGA Investment Management LP

Research Analysts' Recent Ratings Updates for AstraZeneca (AZN) - Daily Political

Amgen News | Markets Insider

AstraZeneca Names Naveen Yamarthi as New India Managing Director, ETGCC

AstraZeneca India appoints new MD and Chennai centre head

Sowell Financial Services LLC Acquires 4,004 Shares of AstraZeneca Plc $AZN - Daily Political

Reply to: 'Interpreting surgical consolidation in oligometastatic gastro-oesophageal cancer'

High Court restrains NPPA from action against AstraZeneca

RNA Targeting Small Molecule Drug Discovery Market - Global Strategic Business Report: Secure a US$5.3B Market by 2030 as Amgen, AstraZeneca, Roche and Merck Accelerate RNA Pipelines

Earnings roundup: AstraZeneca's cost cuts, Alnylam's slump and Regeneron's resilience

27,056 AstraZeneca Plc $AZN Shares Acquired by International Assets Investment Management LLC

D.A. Davidson & CO. Sells 7,410 Shares of AstraZeneca Plc $AZN

1,929,102 Shares of AstraZeneca Plc $AZN Acquired by Bank Julius Baer & Co. Ltd Zurich

UK Stock Market Today: FTSE 100 Futures Edge Up As Traders Brace For BoE

SLS, IBRX, IOVA End October In Red: Merck And AstraZeneca Earnings Put Cancer Bets And Buyout Hopes In Focus

Hutchmed Regulatory Submissions for Orpathys with Tagrisso Accep

AstraZeneca Earnings: Excellent Growth, Three-Year Restructuring Program To Invest in Pipeline | Morningstar

Denosumab in multiple myeloma patients with severe renal impairment: a multicenter phase 2 study

Manufacturing Stocks To Follow Today - November 1st - Daily Political

Cidel Asset Management Inc. Sells 21,125 Shares of AstraZeneca Plc $AZN

AstraZeneca (AZN) Gets a Buy from Bank of America Securities

AstraZeneca (NYSE:AZN) Announces Quarterly Earnings Results, Beats Estimates By $0.19 EPS - Daily Political

AstraZeneca Announces $1.5 Billion Efficiency Drive to Fuel Drug Pipeline Growth, ETPharma

AstraZeneca (NYSE:AZN) Share Price Crosses Above 200 Day Moving Average - Time to Sell?

AstraZeneca (LON:AZN) Share Price Crosses Above Two Hundred Day Moving Average - Time to Sell?

89,287 AstraZeneca Plc $AZN Shares Sold by Apollon Wealth Management LLC

AstraZeneca (LON:AZN) Given "Buy" Rating at Jefferies Financial Group - Daily Political

Q3 earnings round-up: AstraZeneca, AbbVie, Kenvue

Healthcare Stocks Trade Higher: CDNA Gains 20%, REGN Adds 12%, PROF Climbs 10%, AZN Advances 7%

AstraZeneca (NYSE: AZN) Core EPS climbs 14% and full-year guidance holds - Zolmax

AstraZeneca Stocks Rise 7.65% With $2 Billion Restructuring Cost Ceiling

AstraZeneca (LON:AZN) Stock Jumps 7% - What's Next?

Best Manufacturing Stocks To Research - October 30th - Zolmax

Learn Why The Bull Case For AstraZeneca Stock Could Change Following Earnings Beat

AstraZeneca (LON:AZN) Stock Rating Reaffirmed as Buy by Jefferies Financial Group - Markets Daily

Clinics: Biontech, Genmab ADCs hit PFS for breast, ovarian cancer

AstraZeneca (NYSE:AZN) Shares Gap Up - Here's What Happened

AZN Q3 Earnings Beat Estimates, Oncology Drugs Drive Sales Growth

AstraZeneca launches overhaul to cut costs by £1.1bn a year

AstraZeneca profit jumps 23% on cancer drugs as it unveils major savings plan

AstraZeneca Q3 Earnings Call Highlights - Daily Political

AstraZeneca (LON:AZN) Earns "Buy" Rating from Jefferies Financial Group - Stock Observer

AstraZeneca CEO Sees Over $20B Potential From 2027 Drug Trial Readouts - AZN Stock Eyes Breakout After Q3 Earnings Beat

AstraZeneca CFO Aradhana Sarin on Q3 results, oncology portfolio and drug pipeline outlook

Market Open: NatWest Flat Profit, AstraZeneca Revenue Rise

AstraZeneca Q3 Profit Rises; Pipeline Delivers 12 Positive Phase 3 Readouts; Stock Up

AstraZeneca (AZN) Q3 2026 Earnings Results & Report

AstraZeneca Plc $AZN Stake Trimmed by Park Avenue Securities LLC

AstraZeneca Q3 Profit Rises; Reconfirms FY26 Revenue, Core EPS Guidance At CER

AstraZeneca Q3 revenue up 7% as cancer drugs offset Farxiga drop

AstraZeneca Posts Revenue, Profit Growth on Strong Cancer-Drug Sales | Morningstar

AstraZeneca kicks off $1.5 billion savings drive to invest in drug pipeline

Daiichi Sankyo H1 Profit Rises 16% As Cancer Drugs Lift Revenue; Backs FY26 Outlook

Lab Rats series: A Bengaluru startup's bid to drug the undruggable

How Investors May Respond To AstraZeneca (LSE:AZN) EU Breast Cancer Approval

AI CRM Adoption Could Be A Key Catalyst For Veeva Systems Stock (VEEV)

Global HER2 Targeted Therapies Market Report 2026 | Capitalize on 8.6% CAGR as Pfizer, Roche, AstraZeneca, and Daiichi Sankyo Advance ADCs and Precision Oncology

AstraZeneca Bulls Back Drug Pipeline to Boost Laggard Stock

AstraZeneca PLC (LON:AZN) Stock Now Rated "Moderate Buy" by Sell-Side Brokerages

An agentic AI system enhances clinical detection of immune-related adverse events in a multi-phase validation study

5-year outcomes of chemotherapy de-escalation in HER2-positive early breast cancer and exploratory circulating tumor DNA analyses from the randomized phase 2 PHERGain trial

AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker Testing | Morningstar

Mark-Paul Gosselaar on 'Paralysis' of Watching Family Members Navigate Cancer and How It Inspired His Advocacy (Exclusive)

Micron Biomedical Appoints Anand Subramony, Ph.D., as Executive Vice President, Global Product Development and Combination Product Commercialization

AstraZeneca (AZN) Projected to Announce Earnings on Friday

43,432 AstraZeneca Plc $AZN Shares Purchased by Generali Asset Management SPA SGR

AstraZeneca Plc $AZN Stock: Generali Asset Management SPA SGR Grows Holdings - Markets Daily

Cardiff Names Alland Interim Medical Chief Ahead Of Planned Phase 3 Cancer Trial

Erste Group Bank Lowers Earnings Estimates for AstraZeneca - Daily Political

AstraZeneca may start work on cancer vaccines, CEO says

AstraZeneca May Enter Cancer Vaccine Development, CEO Says

AstraZeneca offers compelling risk-reward into 2027 pipeline readouts, says JPMorgan

AstraZeneca, Daiichi Sankyo's Enhertu Wins First EU Approval In Early Breast Cancer Setting

AstraZeneca Names Onco360 National Speciality Pharmacy Partner For Zegfrovy

Valley National Advisers Inc. Sells 12,839 Shares of Astrazeneca Plc $AZN

AstraZeneca, Daiichi Sankyo Drug Gets EU Nod in Early-Stage Breast Cancer | Morningstar

AstraZeneca Projects $80 Bln In Total Revenue By 2030, Sustained Growth Beyond

Innate Pharma: PACIFIC-9 Phase 3 Trial Readout Timing Updated to H1 2027

Ctrl, Alt, Cure: AI codes next miracle drug

AstraZeneca Highlights Breakthrough Cancer Data at ESMO 2026 Investor Update

Is AstraZeneca's Pipeline Fuel Enough to Spark a Post-Earnings Breakout on Oct. 30?

AstraZeneca's Sone-Ve Cuts Death Risk By 42% In Advanced Gastric Cancer Trial; Stock Up

AstraZeneca's Tagrisso Combo Achieves Significant Survival Benefit In Lung Cancer Trial; Stock Up

Cancer Innovation Must Not Become Corporate Spoils -By Fransiscus Nanga Roka

Dow Jones Top Company Headlines at 3 AM ET: Roche Targets Emerging Oncology Market With New Lung-Cancer Drug | AstraZeneca ... | Morningstar

UK Stock Market Today: FTSE 100 Futures Dip As Firm PMIs Meet Rate Worries

AstraZeneca's Sone-ve Drug Shows Promising Survival Rates in Advanced Stomach Cancer Trials, ETPharma

Summit Therapeutics Plc (SMMT) Stock Price, News, Earnings & Company Profile

EMEA Morning Briefing: Central Bank Decisions in Focus This Week | Morningstar

Dow Jones Top Company Headlines at 1 AM ET: AstraZeneca Readies New Portfolio of Targeted Cancer Therapies | Musk ... | Morningstar

Dow Jones Top Company Headlines at 11 PM ET: AstraZeneca Readies New Portfolio of Targeted Cancer Therapies | Musk ... | Morningstar

Notorious Vancouver escort charged with robbery in Ontario | Watch News Videos Online